ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

DCPC Board Okays Recompetition Of Computer Contract

May 30, 1986

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

DCBD To Increase Emphasis On Workshops, Cut Program Initiatives

November 8, 1985